Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis

Abstract Background COVID-19 threatens to quickly overwhelm our existing critical care infrastructure in the USA. Systemic tissue plasminogen activator (tPA) has been previously demonstrated to improve PaO2/FiO2 (mmHg) when given to critically ill patients with acute respiratory distress syndrome (A...

Full description

Bibliographic Details
Main Authors: Rashikh Choudhury, Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Robert C. McIntyre, Peter K. Moore, Daniel S. Talmor, Trevor L. Nydam, Michael B. Yaffe
Format: Article
Language:English
Published: BMC 2020-04-01
Series:World Journal of Emergency Surgery
Subjects:
COVID-19
Acute respiratory distress syndrome (ARDS)
Tissue plasminogen activator (tPA)
Pulmonary failure
Fibrinolysis
Markov
Online Access:http://link.springer.com/article/10.1186/s13017-020-00305-4

Internet

http://link.springer.com/article/10.1186/s13017-020-00305-4

Similar Items